Toripalimab Combined With Gemcitabine/5–fluoropyrimidine for Advanced Cholangiocarcinoma
Condition(s):Advanced CholangiocarcinomaLast Updated:July 16, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Advanced CholangiocarcinomaLast Updated:July 16, 2019Unknown status
Condition(s):Breast CancerLast Updated:December 3, 2012Unknown status
Condition(s):Artificial Intelligence; SurveillanceLast Updated:March 9, 2023Not yet recruiting
Condition(s):Lung CancerLast Updated:March 4, 2024Recruiting
Condition(s):Nasopharyngeal Carcinoma; Head and Neck Cancer; Toxicity Due to RadiotherapyLast Updated:June 11, 2020Unknown status
Condition(s):Pain; Nasopharyngeal Carcinoma; Head and Neck Cancer; Radiation Induced Oral MucositisLast Updated:July 29, 2020Unknown status
Condition(s):Carcinoma, Non-Small-Cell Lung; Stage IV; Thoracic RadiotherapyLast Updated:December 26, 2018Unknown status
Condition(s):ST-segment Elevation Myocardial Infarction (STEMI)Last Updated:September 18, 2023Recruiting
Condition(s):Gastrointestinal Neoplasm MalignantLast Updated:September 8, 2023Recruiting
Condition(s):Intramural HematomaLast Updated:June 3, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.